AzTrials
AzTrials

Under NutritionM-SAKHINCT02457923

Mobile -Solutions Aiding Knowledge for Health Improvement

A study testing Mobile phone counselling in people with Under Nutrition, run by Lata Medical Research Foundation, Nagpur at 1 site in India.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Using a community-based, cluster randomized controlled trial design (cRCT) the investigators will examine the impact of an integrated "m-health package -(M- SAKHI) for mothers on appropriate infant feeding practices, starting in the first / second trimester of pregnancy to 24 months after delivery, to improve child… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Under Nutrition
What is being tested?
Mobile phone counselling
Type of treatment
Vaccines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
2,728 participants
Where
1 siteIndia
Study dates
1 Feb 2017to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • A population of 1000-2000 (ranging from 751-2000) persons and geographically at a distance from other selected villages
  • Within 100 kms distance from the study co-ordinating centre
  • With good cell phone network connectivity (>70%)
  • At least 80% of households with at least one cell phone
  • Staff of the public health system willing to participant in the study.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

India1 site
  • Public Health system

    Nagpur, Maharashtra, 440022

Other trials in India

About this study

Official title: Mobile Health Solutions to Help Community Providers Promote Maternal & Infant Nutrition & Health - A Community-based Cluster RCT in Rural India to Evaluate M-SAKHI for Use by ASHAs to Reduce Malnutrition in Infants up to 24 Months

Using a community-based, cluster randomized controlled trial design (cRCT) the investigators will examine the impact of an integrated "m-health package -(M- SAKHI) for mothers on appropriate infant feeding practices, starting in the first / second trimester of pregnancy to 24 months after delivery, to improve child feeding practices and child growth, and reduce the prevalence of undernutrition in their children. This will result in two treatment groups. The clusters for the trial will be villages under the administrative area of ASHAs (Accreditated Social Health Activists). Villages with a population of 1000- 2000 (ranging from 751 to 2000) with 1 ASHA will be randomized to receive intervention (intervention villages) or continue existing delivery of care (control villages). The data will be collected using a longitudinal design because the investigators want to study the impact of intervention on the mothers starting at pregnancy until her infant is 24 month old.

Read the detailed description
  1. Study design: Using a community-based, cluster randomized controlled trial design (cRCT) the investigators will examine the impact of an integrated "m-health package - (M- SAKHI) for mothers on appropriate infant feeding practices, starting in the first / second trimester of pregnancy to one year after delivery, to improve child feeding practices and child growth, and reduce the prevalence of undernutrition in their children. This will result in two treatment groups (see diagram). The clusters for the trial will be villages under the administrative area of ASHAs. Villages with a population of 1000- 2000 (ranging from 751 to 2000) with single ASHA will be randomized to receive either this intervention (intervention villages) or continue with existing delivery of care (control villages). Selecting a single village per ASHA criteria will reduce the chances of contamination of study groups. The data will be collected using a longitudinal design because the investigators want to study the impact of intervention on the mothers starting at pregnancy until her infant is 24 month old. This is preferred to a cross sectional design to reduce the impact due to migration of mothers in or out of the clusters, who may not receive the intervention as planned. Cross sectional surveys are better suited if a before and after intervention design is used. Lastly on-going government programs can contaminate the intervention in a before-after cross section design. However in a CRCT, the government programs will be present in both study and control clusters, so the additional impact of the intervention can be evaluated. Additionally, growth velocity and development of an infant whose mother is receiving the intervention can also be evaluated using a longitudinal design.

This design will control for potential confounding factors (Observed and unobserved) because an adequate number of clusters (292 villages) will be randomly allocated to the treatment groups. This random allocation of treatments by villages will reduce selection bias that would arise if better performing PHCs with favorable local conditions were purposely selected. Contamination of intervention will be constrained by the administrative and geographic separation of the villages, and by buffer areas.

The outcome assessments will be made by field research officers (FROs) on a cohort of 2,728 mother-infant dyads (1,364 in each treatment group) measured at baseline and at follow up visits. There will be follow-up assessments every trimester during pregnancy and every month from birth until the children are 12 months of age, and then every three or 6 months till 24 months. Three of these assessments (when infants are 15,18 \& 24 months) will be made after the education intervention has ceased in order to assess the sustained impact on the prevalence of child stunting and infant feeding practices (see evaluation plan or details). The investigators expect a likely high correlation between baseline and follow up outcome measures, and low loss to follow up, thus making this approach the most efficient study design.

In this cRCT the interventions will be allocated at a community level, but the outcome assessments will be at the individual level. This is the best comparative design for the proposed interventions, which if delivered to individual mothers would most likely lead to contamination of the intervention in the densely populated rural village communities.

The proposed field area will be the centrally located villages in the catchment areas of Indian Government, PHC in 3 districts (Nagpur, Bhandara and Wardha) of eastern Maharashtra (see Map).There are around 28 PHCs.Each Primary Health Centre (PHC) covers an average population of 30,000 with an average of 30 villages. The administrative area under an ASHA is villages with population of 1000-200 (range of 751 to 2000).

As per the investigators' experience in the Maternal and Neonatal Health (MNH) Registry, the Crude Birth Rate (CBR) of the study area is 16.4 per 1000 population, thus expected or projected number of ante-natal cases (ANC) per thousand populations would be 18 per year considering 10 per cent pregnancy wastage.

At any given point of time, 60 per cent ANCs (11) will be available per thousand population, of which 6 will be up to 20 weeks of gestation. An additional 6 can be registered during next 3 months of enrollment period.

Using standard formulae, the sample size required would be 2,728 mother-infant pairs (1,364 per group) from 292 clusters .This sample would provide 90% power to detect a 15% relative reduction in stunting. Based on prior experience the investigators estimate that after accounting for probable cases of loss to follow-up and delivery outside the study area, about 70 percent of ANCs would be available for inclusion in the study. Thus 8 ANCs per 1000 population would be available for inclusion in the study and a population of 341000 needs to be covered to get required number (2728) subjects.

The unit of randomization will be the ASHA who provides her services to a village with a average population of 1000-2000 (ranging from 751 - 2000) persons. Using a computerized random number generator the investigators will randomize 146 ASHA (1 ASHA per village) to deliver services to pregnant women till her infant is 12 months using the M-SAKHI intervention in addition to the exiting services (intervention group), and, 146 to control group i.e routine provision of services or existing level of service delivery (uniform allocation), across each geographic area. The random allocation sequence will be generated using Stata® software.

All efforts will be made to enroll the women in their first / second trimester (up to 20 weeks of gestation). In both arms, to encourage women to enroll as early as possible, the eligible couples will be identified by ASHA and incentivized by home pregnancy test kits, so that they could report as soon they missed their periods. The average expected number of births for the population covered by 292 villages in the PHCs over 12 months would be 3000, which would be more than required for trial recruitment, thus confirming the feasibility of the sampling scheme.

Conditions
Under Nutrition
Being tested
Mobile phone counselling
Keywords
mobile phone counselling, infant feeding, nutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile phone counsellingOther

    Also called Mobile app for data collection

    1. Data collection and counselling by ASHA using the cell application (App) developed by CommCare Dimagi ii) Mobile phone counselling iii) Routine counselling schedules
Study groups in NCT02457923
Study groupRoleWhat they receive
Mobile phone counsellingExperimentalThe intervention will include: * An "App" for real time data collection of mothers by ASHAs, data transfer, and, display of counselling messages and health video during ASHAs monthly home visit. * Weekly voice and text messages from server at a prescribed time to provide targeted information on infant feeding counselling. * Server generated reminders and alerts, delivered to the mother, ASHA and ANM. * An "App" for field supervisor to monitor ASHAs * Women will receive fortnightly mobile phone counselling calls by an ANM at times they recommend. Need based counselling will also be provided
Receives: Other: Mobile phone counselling
Usual health care servicesNo interventionThe control clusters to receive usual health care services at PHC. The existing data collection methods will be continued in these clusters. Routine IYCF counseling is provided in existing level of care and its frequency is consistent with the visit schedule described in the intervention group: at antenatal clinics; at delivery; and at immunization clinics postnatal.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in the percentage of stunted infants

    Changes in the percentage of stunted infants (height-for-age <-2 Z) at 6, 12, 15,18 and 24 months as measured in follow up assessments starting from birth

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 May 2015 (estimated)
  2. Study start1 Feb 2017
  3. Primary completion31 Dec 2019 (estimated)
  4. Study completion31 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
2,728 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02457923
Sponsor's protocol ID
02_MSAKHI
Acronym
M-SAKHI
Status last verified
Mar 2019
First submitted
14 May 2015
Last updated
15 Mar 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, Mathers C, Rivera J; Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet. 2008 Jan 19;371(9608):243-60. doi: 10.1016/S0140-6736(07)61690-0. No abstract available.

    PubMed 18207566
  • Institute for Health Metrics and Evaluation. GBD Heatmap. 2013. http://www.healthmetricsandevaluation.org/gbd/visualizations/gbdheatmap (accessed 10th March 2013).

  • Stevens GA, Finucane MM, Paciorek CJ, Flaxman SR, White RA, Donner AJ, Ezzati M; Nutrition Impact Model Study Group (Child Growth). Trends in mild, moderate, and severe stunting and underweight, and progress towards MDG 1 in 141 developing countries: a systematic analysis of population representative data. Lancet. 2012 Sep 1;380(9844):824-34. doi: 10.1016/S0140-6736(12)60647-3. Epub 2012 Jul 5.

    PubMed 22770478
  • Christian P, Lee SE, Donahue Angel M, Adair LS, Arifeen SE, Ashorn P, Barros FC, Fall CH, Fawzi WW, Hao W, Hu G, Humphrey JH, Huybregts L, Joglekar CV, Kariuki SK, Kolsteren P, Krishnaveni GV, Liu E, Martorell R, Osrin D, Persson LA, Ramakrishnan U, Richter L, Roberfroid D, Sania A, Ter Kuile FO, Tielsch J, Victora CG, Yajnik CS, Yan H, Zeng L, Black RE. Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low- and middle-income countries. Int J Epidemiol. 2013 Oct;42(5):1340-55. doi: 10.1093/ije/dyt109. Epub 2013 Aug 6.

    PubMed 23920141
  • Dewey KG, Brown KH. Update on technical issues concerning complementary feeding of young children in developing countries and implications for intervention programs. Food Nutr Bull. 2003 Mar;24(1):5-28. doi: 10.1177/156482650302400102.

    PubMed 12664525
  • Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, Ezzati M, Grantham-McGregor S, Katz J, Martorell R, Uauy R; Maternal and Child Nutrition Study Group. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013 Aug 3;382(9890):427-451. doi: 10.1016/S0140-6736(13)60937-X. Epub 2013 Jun 6.

    PubMed 23746772
  • Patel A, Badhoniya N, Khadse S, Senarath U, Agho KE, Dibley MJ; South Asia Infant Feeding Research Netwoork. Infant and young child feeding indicators and determinants of poor feeding practices in India: secondary data analysis of National Family Health Survey 2005-06. Food Nutr Bull. 2010 Jun;31(2):314-33. doi: 10.1177/156482651003100221.

    PubMed 20707236
  • Patel A, Pusdekar Y, Badhoniya N, Borkar J, Agho KE, Dibley MJ. Determinants of inappropriate complementary feeding practices in young children in India: secondary analysis of National Family Health Survey 2005-2006. Matern Child Nutr. 2012 Jan;8 Suppl 1(Suppl 1):28-44. doi: 10.1111/j.1740-8709.2011.00385.x.

    PubMed 22168517
  • Bhutta ZA, Ahmed T, Black RE, et al. Maternal and Child Undernutrition 3: What works? Interventions for maternal and child undernutrition and survival. Child-Care Health and Development 2008; 34(3): 404-.

  • Shrimpton R, Victora CG, de Onis M, Lima RC, Blossner M, Clugston G. Worldwide timing of growth faltering: implications for nutritional interventions. Pediatrics. 2001 May;107(5):E75. doi: 10.1542/peds.107.5.e75.

    PubMed 11331725
  • Victora CG, de Onis M, Hallal PC, Blossner M, Shrimpton R. Worldwide timing of growth faltering: revisiting implications for interventions. Pediatrics. 2010 Mar;125(3):e473-80. doi: 10.1542/peds.2009-1519. Epub 2010 Feb 15.

    PubMed 20156903
  • Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull. 2009;92:7-32. doi: 10.1093/bmb/ldp028.

    PubMed 19776034
  • Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS; Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet. 2003 Jul 5;362(9377):65-71. doi: 10.1016/S0140-6736(03)13811-1.

    PubMed 12853204
  • International Institute for Population Sciences (IIPS), ORC Macro. National Family Health Survey (NFHS-3), 2005-06: India. Mumbai: IIPS 2006; Vol. 1.

  • International Institute for Population Sciences (IIPS). Comprehensive Nutrition Survey in Maharashtra (CNSM). Fact Sheet. 2012

Questions about this trial

What is this clinical trial studying?

A study testing Mobile phone counselling in people with Under Nutrition, run by Lata Medical Research Foundation, Nagpur at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in the percentage of stunted infants (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02457923, which also lists 27 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in